Evidence map›Paper›PMID 35482014›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2022

A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder.

Suma P Shankar, Kristin Grimsrud, Louise Lanoue, Alena Egense, Brandon Willis, Johanna Hörberg, Lama AlAbdi, Klaus Mayer, Koray Ütkür, Kristin G Monaghan and 11 more

Erratum issued Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT02450851 (Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02450851 recruitingnot on this map

Clinical and Genetic Evaluation of Patients With Undiagnosed Disorders Through the Undiagnosed Diseases Network

TypeobservationalSponsorNational Human Genome Research Institute (NHGRI)Ran2015 to 2028Enrolled20,000ConditionsGenetic Disease
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Integrative analysis of the role of theTranslational cancer research · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Biomolecules · 2023
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 4 countries.

Suma P ShankarDivision of Genomic Medicine, UC Davis Health MIND Institute, Department of Pediatrics, UC Davis Health, University of California, Davis, Sacramento, CA; Department of Ophthalmology and Vision Science, UC Davis Health, University of California, Davis, Sacramento, CA. Electronic address: spshankar@ucdavis.edu.
Kristin GrimsrudDepartment of Pathology and Laboratory Medicine, UC Davis Health, University of California, Davis, Sacramento, CA; UC Davis Mouse Biology Program, University of California, Davis, Davis, CA.
Louise LanoueUC Davis Mouse Biology Program, University of California, Davis, Davis, CA.
Alena EgenseDivision of Genomic Medicine, UC Davis Health MIND Institute, Department of Pediatrics, UC Davis Health, University of California, Davis, Sacramento, CA.
Brandon WillisUC Davis Mouse Biology Program, University of California, Davis, Davis, CA.
Johanna HörbergDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Lama AlAbdiDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia; Department of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Klaus MayerRoche Pharma Research and Early Development (pRED), Roche Innovation Center Munich (RICM), Penzberg, Germany.
Koray ÜtkürDivision of Microbiology, Institute of Biology, University of Kassel, Kassel, Germany.
Kristin G MonaghanGeneDx, Gaithersburg, MD.
Joel KrierDivision of Genetics, Brigham and Women's Hospital, Boston, MA; Undiagnosed Diseases Network.
Joan StolerUndiagnosed Diseases Network; Division of Genetics and Genomics, Boston Children's Hospital, Boston, MA.
Maha AlnemerDepartment of Obstetrics & Gynecology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Prabhu R ShankarDivision of Health Informatics, Department of Public Health Sciences, School of Medicine, University of California, Davis, Sacramento, CA.
Raffael SchaffrathDivision of Microbiology, Institute of Biology, University of Kassel, Kassel, Germany.
Fowzan S AlkurayaDepartment of Translational Genomics, Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Ulrich BrinkmannRoche Pharma Research and Early Development (pRED), Roche Innovation Center Munich (RICM), Penzberg, Germany.
Leif A ErikssonDepartment of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, Sweden.
Kent LloydUC Davis Mouse Biology Program, University of California, Davis, Davis, CA; Department of Surgery, UC Davis Health, University of California, Davis, Sacramento, CA.
Katherine A RauenDivision of Genomic Medicine, UC Davis Health MIND Institute, Department of Pediatrics, UC Davis Health, University of California, Davis, Sacramento, CA.
Undiagnosed Diseases NetworkUndiagnosed Diseases Network.
University of California System · USUniversity of California, Davis · USKing Faisal Specialist Hospital & Research Centre · SAUniversity of Gothenburg · SEUC Davis Health · USBoston Children's Hospital · USRoche Pharma AG (Germany) · DEUniversity of Kassel · DEBrigham and Women's Hospital · US

Funding

KOMP2-Phase3 Production and Phenotyping by the DTCC Consortium TCP Transfer to UC DavisUM1OD023221 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2016 to 2026
$45.7M
UCD Mutant Mouse Regional Resource CenterU42OD012210 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2012 to 2026
$29.2M
Resource ProjectU41HG006834 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI REHM, HEIDI L · 2013 to 2020
$26.9M
Center for Integrated Approaches to Undiagnosed DiseasesU01HG007690 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI LOSCALZO, JOSEPH · 2014 to 2022
$10.4M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Lea K Davis · 2020 to 2026
$10.3M
Characterizing the Impact of Genetic Polymorphism on Fentanyl Efficacy and Tolerance in PediatricsK01OD026608 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GRIMSRUD, KRISTIN NICOLE · 2019 to 2023
$731k
NHGRI NIH HHS U01 HG007690NHGRI NIH HHS U41 HG006834NICHD NIH HHS P50 HD103537NIH HHS K01 OD026608NIH HHS L30 OD030193NIH HHS U42 OD012210NIH HHS UM1 OD023221
6 · The paper itself

Abstract

purposeDiphthamide is a post-translationally modified histidine essential for messenger RNA translation and ribosomal protein synthesis. We present evidence for DPH5 as a novel cause of embryonic lethality and profound neurodevelopmental delays (NDDs).

methodsMolecular testing was performed using exome or genome sequencing. A targeted Dph5 knockin mouse (C57BL/6Ncrl-Dph5

resultsDPH5 variants p.His260Arg (homozygous), p.Asn110Ser and p.Arg207Ter (heterozygous), and p.Asn174LysfsTer10 (homozygous) were identified in 3 unrelated families with distinct overlapping craniofacial features, profound NDDs, multisystem abnormalities, and miscarriages. Dph5 p.His260Arg homozygous knockin was embryonically lethal with only 1 subviable mouse exhibiting impaired growth, craniofacial dysmorphology, and multisystem dysfunction recapitulating the human phenotype. Adenosine diphosphate-ribosylation assays showed absent to decreased function in DPH5-knockout human and yeast cells. In silico modeling of the variants showed altered DPH5 structure and disruption of its interaction with eEF2.

conclusionWe provide strong clinical, biochemical, and functional evidence for DPH5 as a novel cause of embryonic lethality or profound NDDs with multisystem involvement and expand diphthamide-deficiency syndromes and ribosomopathies.

Indexed as

MethyltransferasesNeurodevelopmental DisordersAdenosine DiphosphateAnimalsHistidineHumansMiceMice, Inbred C57BLSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSyndromeAdenosine DiphosphatediphthamideDPH5 protein, S cerevisiaeHistidineMethyltransferasesSaccharomyces cerevisiae ProteinsNonverbal neurodevelopment delaysNovel gene discoveryPrecision animal modelingPrecision genomicsTranslational genetics

Identifiers

PMID35482014
PMCPMC9426662
OpenAlexW4225094783

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.